John Heimlich - Portage MI, US Loksidh Ganorkar - Kalamazoo MI, US Ernest Lee - Kalamazoo MI, US Robert Noack - Grand Rapids MI, US Ronald VerHage - Lawton MI, US
The present invention relates to zero-order sustained release solid dosage forms suitable for administration of a wide range of therapeutically active medicaments, especially those that are water-soluble, and to a process of making same. The solid dosage form comprises (a) a matrix core comprising ethylcellulose and the active agent and (b) a hydrophobic polymer coating encasing the entire matrix core.
Multiple Pulse Extended Release Formulations Of Clindamycin
John Heimlich - Portage MI, US Robert Noack - Grand Rapids MI, US Steven Cox - Schoolcraft MI, US Loksidh Ganorkar - Kalamazoo MI, US Ronald VerHage - Lawton MI, US Ernest Lee - Kalamazoo MI, US
International Classification:
A61K031/704 A61K009/22 A61K009/26
US Classification:
424/470000, 514/035000
Abstract:
The present invention is directed to an oral dosage form for multiple-pulsed delivery of at least two fractions of clindamycin to a subject, one in an immediate-release form and the other in an extended release form. The oral dosage forms of the present invention provide a means for treating or preventing gram-positive bacterial infections with a minimal number of treatments per day, potentially, as little as once or twice per day.